发明名称 |
INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE. |
摘要 |
The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ≥ 0.5 mg naloxone HCl dissolved in an application fluid of a volume of ≤ 250 µl. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof. |
申请公布号 |
MX2013013276(A) |
申请公布日期 |
2014.08.07 |
申请号 |
MX20130013276 |
申请日期 |
2012.05.11 |
申请人 |
EURO-CELTIQUE S.A. |
发明人 |
JOHN STRANG;ALEXANDER OKSCHE;STEPHEN HARRIS;KEVIN SMITH;LUCIE HELENE JEANNE MOTTIER |
分类号 |
A61K31/485;A61K9/00;A61K9/08;A61K9/72;A61K31/135;A61P25/36 |
主分类号 |
A61K31/485 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|